Clear Cell Sarcoma Foundation
Stomping Out Sarcoma
Programs and results
What we aim to solve
Clear Cell Sarcoma has been defined as an ultra rare sarcoma by the international sarcoma community that affects less than 300 patients per year in the US. We believe those numbers are much higher but lack an international insurance code to correctly track the numbers and gather data. Those affected are primarily adolescents and young adults and the disease is often very aggressive. Diagnosis is often missed causing deadly outcomes. There are no known effective treatments for long term survival. There are very few research materials such as tissue and natural history studies of the disease leaving scientists and clinicians grossly unaware of this rare cancer.
Our programs
What are the organization's current programs, how do they measure success, and who do the programs serve?
CCSF Research Funding
We are raising money to fund patient travel to access a first of its kind clear-cell sarcoma trial currently in phase I/II. We are working directly with the FDA as well as top scientists/researchers in the clear-cell sarcoma field.
Patient Registry/Natural History Survey
Sara’s Cure is working to create a first ever patient registry for clear cell sarcoma
Where we work
External reviews

Our results
How does this organization measure their results? It's a hard question but an important one.
Number of meetings with policymakers or candidates
This metric is no longer tracked.Totals By Year
Related Program
CCSF Research Funding
Type of Metric
Outcome - describing the effects on people or issues
Direction of Success
Increasing
Context Notes
Policymakers and candidates include those that write protocols and approve drug trials. This can be pharma, FDA or those that influence research
Number of coalition meetings
This metric is no longer tracked.Totals By Year
Type of Metric
Context - describing the issue we work on
Direction of Success
Increasing
Number of community events or trainings held and attendance
This metric is no longer tracked.Totals By Year
Related Program
Patient Registry/Natural History Survey
Type of Metric
Output - describing our activities and reach
Direction of Success
Increasing
Context Notes
To include fundraising events, education, nano course, patient focus groups
Number of individuals attending community events or trainings
This metric is no longer tracked.Totals By Year
Type of Metric
Output - describing our activities and reach
Direction of Success
Increasing
Context Notes
This number is hard to measure unless the events are invitation only. Many during COVID were by zoom. these are estimates based from our donor platform contacts
Goals & Strategy
Learn about the organization's key goals, strategies, capabilities, and progress.
Charting impact
Four powerful questions that require reflection about what really matters - results.
What is the organization aiming to accomplish?
Clear Cell Sarcoma Foundation began when our daughter was prescribed a treatment for another sarcoma that has been shown to spread the CCS. This is the standard "go to" for many peds patients and we aim to change that by being the hub of information for doctors, scientists and patients. We do this work to not only bring awareness to this ultra rare cancer but to save lives through educating the medical world, supporting tissue collection and inspiring research that will lead to a cure. We aim to create the foundation for a better future for CCS and ultra rare sarcoma without a voice.
What are the organization's key strategies for making this happen?
Clear Cell Sarcoma Foundation (Formerly Sara's Cure) funded repurposed drugs testing on clear cell sarcoma cell lines to find a combination that will work on this horrible cancer. We are establishing a patient driven and patient reported natural history documentation to compile critical information for doctors, scientists and patients to direct how to treat and how NOT to treat for best outcomes. Keeping patients alive through best practices like surgery and not unproven random treatments allows patients to direct their treatments and to engage more and take on the roles of advocates within our organization. Our CCS family is empowered and engaged. By keeping this organization running smoothly and providing a place for the patient to be "seen and heard" Clear Cell Sarcoma will be launched into the realm of public research where discoveries are made.
What are the organization's capabilities for doing this?
Our capabilities come from our financial supporters and patients through the funding we receive that allows us to get in front of the regulators, attend conferences with drug developers and advise the bodies that oversee medical research in areas of unmet need. All of this combined gives the patient community a place to be seen and heard. Clinicians have awakened to the CCS families existence and they hear the patients voices through our constant contact and participation in all types of sarcoma based opportunities like conferences and coalitions. Being the only patient focused advocacy organization for CCS brings the world of patients together in one place and makes our voice too loud to ignore. No one should hear the words "your child has clear cell sarcoma and we don't have a treatment" ever again.
What have they accomplished so far and what's next?
Clear Cell Sarcoma Foundation has awakened the research and science world to to our rare cancer type. In our short existance we have convinced the FDA to work with us and a small drug company on creating a first ever CCS trial based on preclinical evidence in the lab. We are funding the patient travel. We offer patients a platform to voice their concerns, struggles, treatments, reports and more. We are an organization that lets them know that although their cancer is Ultra Rare they are not alone. We facilitate peer to peer support so no patient is isolated and led to believe they are alone. We have created a seat at the sarcoma table with the pharmaceutical world, oncology world, rare disease community and the governmental regulatory agencies by participating in councils and task force meetings as well as holding leadership positions in sarcoma. We have been included on a grant with The Broad Institute to create critical research materials for the scientific community. We have built the momentum to find the cure. Our future goals are to keep supporting advancing less toxic treatments and supporting other ultra rare sarcoma subtypes like we have been supported
Financials
Unlock nonprofit financial insights that will help you make more informed decisions. Try our monthly plan today.
- Analyze a variety of pre-calculated financial metrics
- Access beautifully interactive analysis and comparison tools
- Compare nonprofit financials to similar organizations
Want to see how you can enhance your nonprofit research and unlock more insights?
Learn more
about GuideStar Pro.
Operations
The people, governance practices, and partners that make the organization tick.
Connect with nonprofit leaders
SubscribeBuild relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.
- Analyze a variety of pre-calculated financial metrics
- Access beautifully interactive analysis and comparison tools
- Compare nonprofit financials to similar organizations
Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.
Connect with nonprofit leaders
SubscribeBuild relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.
- Analyze a variety of pre-calculated financial metrics
- Access beautifully interactive analysis and comparison tools
- Compare nonprofit financials to similar organizations
Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.
Clear Cell Sarcoma Foundation
Board of directorsas of 09/22/2022
Mrs. Laneen Woods
Lowcountry Living Group
Term: 2018 -
Jenae Heyligers Heller
Imagineer Technology
Bruce Newby
Medical Sales Company
Nan Deturk
Black Powder Advisors
Dru Williams
Rogue Motion
Kelley Argraves
CDMRP
Dawn Judd
Hindke and Clarey
Evan Barnes
Branded by Greenville
Dennis Woods
Dade Paper